Question Bank › Uncontested runway

Uncontested runway

Uncontested runway: the obstacles management narrates are execution and time, not rivals

Calls Tested
474
Answered YES
268
Hit Rate
56.5%
rare by design

Ingevity Corporation (NGVT) — this company's answers

NO on the Q4 2021 call 2022-02-25 B
The model's full reasoning — Q4 2021 call → NO我们根据提供的财报电话会议记录来判断。管理层在解释当前业绩与更大业务量之间的障碍时,是否主要叙述的是公司自身的执行和日历(如建设、生产、招聘、培训、认证、安装、上线、开放、爬坡、转换或交付),而不是其他卖家争夺同一需求? 分析:管理层在多个地方提到了增长路径,例如: - Performance Chemicals:新产能(Crossett的替代脂肪酸产能,DeRidder的多元醇产能)正在上线,预计2022年Q2投产。 - Performance Materials:微芯片短缺导致汽车产量受限,但预计会恢复,并提到巴西、欧洲、中国的法规推动增长。 - 提到供应链优势,帮助客户,获得市场份额(如粘合剂业务)。 - 提到持续投资于增长项目,如SAP实施、去瓶颈项目。 关键点:管理层是否将增长障碍归因于自身执行和时间,而不是竞争?在粘合剂部分,他们提到“获得市场份额”作为供应链优势的结果,但整体上,他们更多谈论的是产能建设、法规实施、微芯片短缺(外部因素)等。微芯片短缺是外部供应问题,不是公司自身执行。但管理层也提到“我们预计这会纠正,随着汽车行业产量增加和微芯片供应正常化”,这属于外部条件。 然而,管理层明确提到“我们正在战略性地投资于增长和未来”,并具体说明新产能上线时间。在回答分析师问题时,他们提到“我们正在执行SAP S/4HANA实施”,以及“去瓶颈项目”。这些是公司自身的执行。 但问题问的是:当管理层解释当前结果与更大业务量之间的障碍时,是否叙述的是自身执行和日历,而不是其他卖家竞争?在电话会议中,管理层多次提到微芯片短缺是主要障碍,这是外部供应问题,不是公司自身执行。同时,他们也提到自身产能建设(如新工厂)是增长路径。但微芯片短缺是外部因素,不属于“自身执行和日历”。此外,管理层提到“我们预计微芯片供应将继续受限”,这属于外部条件。 然而,在Performance Chemicals部分,他们提到“我们正在看到原材料成本上涨”,但通过提价抵消。这也不是自身执行。 关键:管理层是否将增长障碍主要归因于自身执行?在回答关于汽车产量的问题时,他们提到“我们正在遵循IHS预测”,并说“我们预计微芯片供应将继续受限”,这属于外部。但他们在描述增长路径时,也提到“我们正在建设新产能”,如DeRidder和Crossett,这些是自身执行。 但问题要求“ONE coherent overall condition with BOTH halves”:即(1)真实路径已经存在,正在工作;(2)竞争缺席。在电话会议中,管理层确实提到了增长路径(新产能、法规推动),但竞争方面,他们提到“获得市场份额”在粘合剂业务,但整体上,他们并没有将增长描述为与竞争对手争夺,而是更多描述为自身产能和外部条件(微芯片)。然而,微芯片短缺是外部条件,不是自身执行。 再仔细看:管理层说“我们预计这会纠正,随着汽车行业产量增加和微芯片供应正常化”,这属于外部。但他们在描述Performance Materials时,提到“我们正在执行去瓶颈项目”,这是自身执行。但主要障碍是微芯片短缺,这是外部。 问题问的是“obstacles it actually narrates”是否主要是自身执行和日历。在电话会议中,管理层多次提到微芯片短缺是主要障碍,这属于外部供应短缺,不是自身执行。同时,他们也提到自身产能建设,但那是增长路径,不是障碍。障碍是微芯片短缺,这是外部。 因此,答案应为NO,因为主要障碍是外部条件(微芯片短缺),而不是公司自身执行和日历。 但注意:管理层也提到“我们预计微芯片供应将继续受限”,这属于外部。而自身执行如新产能建设是增长机会,不是障碍。所以,障碍是外部。 因此,答案应为NO。

← Back to the full NGVT analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN EXECUTION AND THE CALENDAR — building, producing, hiring, training, qualifying, certifying, installing, onboarding, opening, ramping, converting, or delivering — rather than other sellers competing for the same demand? Answer YES when the transcript conveys, in whatever form fits the industry, ONE coherent overall condition with BOTH halves present in management's own account: (1) A REAL PATH TO MORE BUSINESS, ALREADY BEING WORKED. Management describes growth that is already in motion or already available to the company — such as demand, orders, customers, programs, projects, openings, capacity, or opportunities the company is actively serving, ramping, or standing up now — and discusses the path to capturing more of it in practical, operator terms: what must be built, staffed, finished, qualified, scaled, or worked through, and roughly how that work is progressing. The specifics may take any form that fits the business; what matters is that management is narrating real work underway toward more business, not merely expressing optimism about a market. (2) THE CONTEST FOR THE DEMAND IS ABSENT FROM THE STORY. Across the call — prepared remarks and answers alike — the demand being pursued is NOT framed as something being fought for against other sellers: management does not center its account on beating competitors, win rates, competitive pricing, discounting to win deals, share battles, or convincing customers to choose it over alternatives, and analysts' competitive probes (if any) do not turn the discussion into a contested-demand story. Instead, the effective limits on growth in management's own telling are the company's own throughput, readiness, and the time things take. It counts whether this is because the company has already been chosen or designed in, because it occupies a niche others do not serve, because demand exceeds what all providers can supply, or for any other reason evident in the transcript — the signal is the CHARACTER OF THE OBSTACLES narrated, not any particular cause. Answer NO if management's account of growth centers on winning, defending, or stimulating demand against alternatives — competitive positioning, displacing rivals, pricing to win, or persuading hesitant buyers. NO if the path to more business is mostly aspiration, pipeline, market size, or plans with no real work underway. NO if the company is chiefly explaining weak demand, excess capacity, cost cutting, restructuring, or a turnaround. NO if the main obstacles narrated are external conditions such as macro weakness, commodity prices, weather, regulation blocking the company, or shortages of purchased inputs, rather than the company's own execution and timing. NO if the execution-and-time framing appears only in an analyst's characterization that management does not itself bear out. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
NOAH Noah Holdings Limited Q1 2024 2024-05-30 D
CRGO Freightos Limited Q1 2024 2024-05-20 C+
RCEL AVITA Medical, Inc. Q1 2024 2024-05-14 F
ERO Ero Copper Corp. Q1 2024 2024-05-10 A
WRBY Warby Parker Inc. Q1 2024 2024-05-09 A
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
ECPG Encore Capital Group, Inc. Q1 2024 2024-05-08 B
FWONK Formula One Group Q1 2024 2024-05-08 C+
LINC Lincoln Educational Services Corporation Q1 2024 2024-05-06 B+
NC NACCO Industries, Inc. Q1 2024 2024-05-05 C+
PPC Pilgrim's Pride Corporation Q1 2024 2024-05-03 A
CW Curtiss-Wright Corporation Q1 2024 2024-05-02 B+
TTI TETRA Technologies, Inc. Q1 2024 2024-05-01 A
WEC WEC Energy Group, Inc. Q1 2024 2024-05-01 A
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
PDS Precision Drilling Corporation Q1 2024 2024-04-25 B
GL Globe Life Inc. Q1 2024 2024-04-23 F
CLGN CollPlant Biotechnologies Ltd. Q4 2023 2024-04-04 F
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
ASM Avino Silver & Gold Mines Ltd. Q4 2023 2024-03-21 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
PBR Petróleo Brasileiro S.A. - Petrobras Q4 2023 2024-03-08 D
MNKD MannKind Corporation Q4 2023 2024-02-27 C
DXCM DexCom, Inc. Q4 2023 2024-02-08 B+
EGP EastGroup Properties, Inc. Q4 2023 2024-02-08 B
GPRO GoPro, Inc. Q4 2023 2024-02-07 F
GPRE Green Plains Inc. Q4 2023 2024-02-07 F
RDCM RADCOM Ltd. Q4 2023 2024-01-31 A
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
CHT Chunghwa Telecom Co., Ltd. Q4 2023 2024-01-30 C
EMKR EMCORE Corporation Q4 2023 2023-12-12 C+
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
CPRT Copart, Inc. Q1 2024 2023-11-16 B+
ICCM IceCure Medical Ltd Q3 2023 2023-11-15 D
EFXT Enerflex Ltd. Q3 2023 2023-11-09 C+
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
MEG Montrose Environmental Group, Inc. Q3 2023 2023-11-08 C+
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
CMPS COMPASS Pathways plc Q3 2023 2023-11-04 F
GOLD Barrick Gold Corporation Q3 2023 2023-11-02 C
AEP American Electric Power Company, Inc. Q3 2023 2023-11-02 C+
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
APAM Artisan Partners Asset Management Inc. Q3 2023 2023-11-01 C+
GRBK Green Brick Partners, Inc. Q3 2023 2023-11-01 B
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
ANGO AngioDynamics, Inc. Q1 2024 2023-10-04 B
PTN Palatin Technologies, Inc. Q4 2023 2023-09-29 D
NBTX Nanobiotix S.A. Q2 2023 2023-09-27 D
BZUN Baozun Inc. Q2 2023 2023-08-28 D
DXLG Destination XL Group, Inc. Q2 2023 2023-08-24 D
KMDA Kamada Ltd. Q2 2023 2023-08-16 B+
APPS Digital Turbine, Inc. Q1 2024 2023-08-08 D
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
HE Hawaiian Electric Industries, Inc. Q2 2023 2023-08-07 C
AKYA Akoya Biosciences, Inc. Q2 2023 2023-08-07 C+
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
ET Energy Transfer LP Q2 2023 2023-08-02 C+
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
CTO CTO Realty Growth, Inc. Q2 2023 2023-07-28 B
MBLY Mobileye Global Inc. Q2 2023 2023-07-28 B+
IMAX IMAX Corporation Q2 2023 2023-07-26 B+
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
GGR Gogoro Inc. Q1 2023 2023-05-11 D
CDE Coeur Mining, Inc. Q1 2023 2023-05-11 C+
SU Suncor Energy Inc. Q1 2023 2023-05-09 C+
SLDP Solid Power, Inc. Q1 2023 2023-05-08 C+
THS TreeHouse Foods, Inc. Q1 2023 2023-05-08 B+
ULCC Frontier Group Holdings, Inc. Q1 2023 2023-05-07 C+
INGN Inogen, Inc. Q1 2023 2023-05-05 F
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TSSI TSS, Inc. Q4 2022 2023-04-03 D
BEAT BioTelemetry's Q4 2022 2023-03-17 D
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
M Macy's, Inc. Q4 2022 2023-03-02 D
TGT Target Corporation Q4 2022 2023-02-28 C
CRBG Corebridge Financial, Inc. Q4 2022 2023-02-22 B
OEC Orion Engineered Carbons S.A. Q4 2022 2023-02-17 B+
TOST Toast, Inc. Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
HIW Highwoods Properties, Inc. Q4 2022 2023-02-08 B
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
ARWR Arrowhead Pharmaceuticals, Inc. Q4 2022 2022-11-28 D
CIG Companhia Energética de Minas Gerais Q3 2022 2022-11-16 C+
CUE Cue Biopharma, Inc. Q3 2022 2022-11-14 D
PKOH Park-Ohio Holdings Corp. Q3 2022 2022-11-13 B
BLZE Backblaze, Inc. Q3 2022 2022-11-11 D
CLSD Clearside Biomedical, Inc. Q3 2022 2022-11-09 C
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
MEC Mayville Engineering Company, Inc. Q3 2022 2022-11-05 B+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
PKX POSCO Holdings Inc. Q3 2022 2022-10-24 D
ASTS AST SpaceMobile, Inc. Q2 2022 2022-08-15 D
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
EVGO EVgo, Inc. Q2 2022 2022-08-09 C+
FLR Fluor Corporation Q2 2022 2022-08-05 D
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
IT Gartner, Inc. Q2 2022 2022-08-02 A
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
LTBR Lightbridge Corporation Q2 2022 2022-07-28 D
LIN Linde plc Q2 2022 2022-07-28 B+
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
SQM Sociedad Química y Minera de Chile S.A. Q1 2022 2022-05-19 C+
YALA Yalla Group Limited Q1 2022 2022-05-17 C
FLYW Flywire Corporation Q1 2022 2022-05-14 B+
ZVIA Zevia PBC Q1 2022 2022-05-12 B
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
WHF WhiteHorse Finance, Inc. Q1 2022 2022-05-10 B+
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
CCRN Cross Country Healthcare, Inc. Q1 2022 2022-05-04 B
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
STC Stewart Information Services Corporation Q1 2022 2022-04-29 C+
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
ZENV Zenvia Inc. Q4 2021 2022-03-17 C+
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
HROW Harrow Health, Inc. Q4 2021 2022-03-10 C
RELY Remitly Global, Inc. Q4 2021 2022-03-02 B
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
AKAM Akamai Technologies, Inc. Q4 2021 2022-02-15 B
FORM FormFactor, Inc. Q4 2021 2022-02-02 B
FFIC Flushing Financial Corporation Q4 2021 2022-01-28 B
HFWA Heritage Financial Corporation Q4 2021 2022-01-27 A
EXP Eagle Materials Inc. Q3 2022 2022-01-27 B
LC LendingClub Corporation Q4 2021 2022-01-26 A
OOMA Ooma, Inc. Q3 2022 2021-12-02 B+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
ZH Zhihu Inc. Q3 2021 2021-11-22 D
RNW ReNew Energy Global Plc Q2 2022 2021-11-18 C
LOW Lowe's Companies, Inc. Q3 2021 2021-11-17 B+
BFI BurgerFi International, Inc. Q3 2021 2021-11-12 C
CXW CoreCivic, Inc. Q3 2021 2021-11-09 C
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
AKBA Akebia Therapeutics, Inc. Q3 2021 2021-11-09 C+
ALHC Alignment Healthcare, Inc. Q3 2021 2021-11-06 B+
KTB Kontoor Brands, Inc. Q3 2021 2021-11-04 A
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
WMB The Williams Companies, Inc. Q3 2021 2021-11-02 B
LMAT LeMaitre Vascular, Inc. Q3 2021 2021-10-29 C+
MD Pediatrix Medical Group, Inc. Q3 2021 2021-10-28 B
FFWM First Foundation Inc. Q3 2021 2021-10-26 B
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
ASAN Asana, Inc. Q2 2022 2021-09-01 B+
TJX The TJX Companies, Inc. Q2 2021 2021-08-18 C
EGY VAALCO Energy, Inc. Q2 2021 2021-08-12 B
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
KNDI Kandi Technologies Group, Inc. Q2 2021 2021-08-09 F
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
GNK Genco Shipping & Trading Limited Q2 2021 2021-08-07 A
UFI Unifi, Inc. Q4 2021 2021-08-07 B
CLVT Clarivate Plc Q2 2021 2021-07-31 B+
AX Axos Financial, Inc. Q4 2021 2021-07-29 C+
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
TENB Tenable Holdings, Inc. Q2 2021 2021-07-27 A
TCBI Texas Capital Bancshares, Inc. Q2 2021 2021-07-21 F
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
PRPO Precipio, Inc. Q3 2018 2018-11-19 D
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
OGE OGE Energy Corp. Q3 2018 2018-11-08 A
ALB Albemarle Corporation Q3 2018 2018-11-08 B
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
WES Western Midstream Partners, LP Q3 2018 2018-10-31 D
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
T AT&T Inc. Q3 2018 2018-10-24 C+
STM STMicroelectronics NV Q3 2018 2018-10-24 C+
LRN Stride, Inc. Q1 2019 2018-10-23 B
ALKS Alkermes plc Q3 2018 2018-10-23 C
AU AngloGold Ashanti's Q2 2018 2018-08-20 B
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
SO The Southern Company Q2 2018 2018-08-08 D
SRDX Surmodics, Inc. Q3 2018 2018-08-06 A
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
YUM Yum! Brands, Inc. Q2 2018 2018-08-02 C
TMHC Taylor Morrison Home Corporation Q2 2018 2018-08-01 B
FMS Fresenius Medical Care AG & Co. KGaA Q2 2018 2018-07-31 C
XOM Exxon Mobil Corporation Q2 2018 2018-07-27 C
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
CP Canadian Pacific Railway Limited Q2 2018 2018-07-19 B+
ASND Ascendis Pharma A/S Q1 2018 2018-05-30 C+
CLMT Calumet Specialty Products Partners, L.P Q1 2018 2018-05-16 C+
LAUR Laureate Education, Inc. Q1 2018 2018-05-13 B+
NOVT Novanta Inc. Q4 2017 2018-05-12 B+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A

How the model reasoned

PPC · Q1 2024 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...YES The transcript frames the path to more business as already underway through operational improvements (hatchability and livability gains), facility expansions in Mexico, and the startup of a protein conversion facility. Management describes these as practical steps—building, ramping, and qualifying capacity—that are in progress, directly addressing current limitations in 2023 results. Demand is tied to customer growth and industry tailwinds like protein switching, but the obstacles cited are internal execution and timing, not competitive battles. No emphasis is placed on winning deals against rivals or pricing strategies; instead, the focus remains on the company's own throughput and readiness.
EVBN · Q4 2016 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...YES The transcript shows management narrating a real path to more business already in motion—market disruption from the KeyBank/First Niagara combination, organic capture, new branch openings, insurance agency acquisitions, core system conversions, hiring, and municipal banking department startup—with concrete operator-level work underway. The obstacles to scaling are framed as internal execution and calendar realities (18-24 month loan migration timelines, 9-month deposit ramps), not as demand being contested against rivals. While some competitive positioning language appears, it does not override the core account of growth limits as throughput and timing constraints rather than win-rate battles.
UPLD · Q4 2017 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...NO The transcript centers on M&A-driven growth through acquisitions and integrations, with organic growth described as flat to 5% and not essential. Management frames the path to more business around building integration capabilities, hiring, training, qualifying, and ramping operations post-acquisition, which aligns with execution and calendar constraints. However the discussion includes competitive elements such as replacing incumbents and displacing rivals in some cases, which introduces a contest for demand. Additionally, the narrative emphasizes the company's own readiness and pipeline rather than purely external factors, but the competitive mentions prevent a clean YES under the criteria.

More from the question bank

Outsized outside commitment, delivery just sCostly self-restriction to protect one part Substance without an audienceQuarter of firsts: the period's story is buiNew business is being written on visibly betPriced for one buyer, wanted by manyAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.